LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Longeveron Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.39+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $43.61M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Longeveron's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Mitchell P. Kopin | 2,941,180 | 9.00% | 13G (passive) amendment | Jun 30, 2026 |
| Logos Global Management LP | 192,308 | 6.30% | 13G (passive) | Sep 2, 2026 |
| Millennium Group Management LLC | 1,553,642 | 5.20% | 13G (passive) | Aug 4, 2026 |
| Janus Henderson Group PLC | 1,291,331 | 5.90% | 13G (passive) | Mar 31, 2026 |
| Joshua M. Hare, M.D | 1,084,888 | 25.70% | 13D (active) amendment | Apr 10, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joshua Hare | Chief Scientific Officer, Director, 10% owner | 10,811,369 | 33.91% | Aug 21, 2026 |
| Nirav S. Jhaveri | Chief Financial Officer | 300,000 | 0.94% | Aug 25, 2026 |
| Paul T. Lehr | General Counsel, Secretary | 1,003,829 | 3.15% | Aug 21, 2026 |
| Nataliya Agafonova | Chief Medical Officer | 737,700 | 2.31% | Aug 21, 2026 |
| Devin Blass | CTO & SVP of CMC | 711,735 | 2.23% | Aug 21, 2026 |
| Marie Washburn | Chief Financial Officer | 101,030 | 0.32% | Jul 21, 2026 |
| Lisa Locklear | Chief Financial Officer | 480,005 | 1.51% | Jul 6, 2026 |
| Stephen H. Willard | Chief Executive Officer | 771,681 | 2.42% | Jul 6, 2026 |
| James Nathaniel Powell | Chief Executive Officer | 125,593 | 0.39% | Jan 6, 2026 |
| Mohamed Wa'el Ahmed Hashad | Chief Executive Officer | 543,547 | 1.70% | Jul 17, 2025 |
| Roger Joseph Hajjar | Director | 69,000 | 0.22% | Aug 21, 2026 |
| Leah Rush Cann | Director | 36,000 | 0.11% | Aug 21, 2026 |
| Deborah Ascheim | Director | 36,000 | 0.11% | Aug 21, 2026 |
| George A. Paletta Jr. | Director | 70,000 | 0.22% | Aug 21, 2026 |
| Arjun JJ Desai | Director | 36,000 | 0.11% | Aug 21, 2026 |
| Ursula Ungaro | Director | 82,000 | 0.26% | Aug 21, 2026 |
| Rock Soffer | Director | 964,385 | 3.02% | Aug 21, 2026 |
| Khoso Baluch | Director | 67,391 | 0.21% | Aug 13, 2025 |
| Richard N. Kender | Director | 33,000 | 0.10% | Jul 17, 2025 |
| Neha J. Motwani | Director | 33,000 | 0.10% | Jul 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Paul T. Lehr General Counsel, Secretary | Aug 19, 2026 | Award | +286,000 | – | – | 861,423 |
| Joshua Hare Chief Scientific Officer, Director, 10% owner | Aug 19, 2026 | Award | +286,000 | – | – | 1,607,796 |
| Rock Soffer Director | Aug 19, 2026 | Award | +36,000 | – | – | 262,034 |
| Roger Joseph Hajjar Director | Aug 19, 2026 | Award | +36,000 | – | – | 69,000 |
| Ursula Ungaro Director | Aug 19, 2026 | Award | +36,000 | – | – | 77,000 |
| Devin Blass CTO & SVP of CMC | Aug 19, 2026 | Award | +286,000 | – | – | 711,735 |
| Arjun JJ Desai Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| George A. Paletta Jr. Director | Aug 19, 2026 | Award | +36,000 | – | – | 70,000 |
| Nataliya Agafonova Chief Medical Officer | Aug 19, 2026 | Award | +286,000 | – | – | 716,914 |
| Deborah Ascheim Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| Leah Rush Cann Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| Nirav S. Jhaveri Chief Financial Officer | Aug 17, 2026 | Award | +300,000 | – | – | 300,000 |
| Joshua Hare Chief Scientific Officer, Director, 10% owner | Jul 6, 2026 | Award | +600,000 | – | – | 1,321,796 |
| Stephen H. Willard Chief Executive Officer | Jul 1, 2026 | Tax withholding | −18,046 | $0.73 | $13.17K | 771,681 |
| Devin Blass CTO & SVP of CMC | Jul 1, 2026 | Tax withholding | −15,808 | $0.73 | $11.54K | 425,735 |
| Paul T. Lehr General Counsel, Secretary | Jul 1, 2026 | Tax withholding | −13,143 | $0.73 | $9.59K | 575,423 |
| Lisa Locklear Chief Financial Officer | Jul 1, 2026 | Tax withholding | −22,505 | $0.73 | $16.43K | 443,181 |
| Nataliya Agafonova Chief Medical Officer | Jul 1, 2026 | Tax withholding | −22,505 | $0.73 | $16.43K | 430,914 |
| Paul T. Lehr General Counsel, Secretary | May 1, 2026 | Award | +250,000 | – | – | 588,566 |
| Stephen H. Willard Chief Executive Officer | May 1, 2026 | Award | +500,000 | – | – | 789,727 |
| Nataliya Agafonova Chief Medical Officer | May 1, 2026 | Award | +250,000 | – | – | 453,419 |
| Lisa Locklear Chief Financial Officer | May 1, 2026 | Award | +250,000 | – | – | 465,686 |
| Devin Blass CTO & SVP of CMC | May 1, 2026 | Award | +250,000 | – | – | 441,543 |
| Nataliya Agafonova Chief Medical Officer | Apr 1, 2026 | Tax withholding | −13,145 | $1.12 | $14.72K | 203,419 |
| Paul T. Lehr General Counsel, Secretary | Apr 1, 2026 | Tax withholding | −5,611 | $1.12 | $6.28K | 338,566 |
| Lisa Locklear Chief Financial Officer | Apr 1, 2026 | Tax withholding | −13,145 | $1.12 | $14.72K | 215,686 |
| Stephen H. Willard Chief Executive Officer | Apr 1, 2026 | Tax withholding | −4,740 | $1.12 | $5.31K | 289,727 |
| Devin Blass CTO & SVP of CMC | Apr 1, 2026 | Tax withholding | −8,633 | $1.12 | $9.67K | 191,543 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Tax withholding | −105,533 | $0.55 | $58.04K | 94,467 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Award | +200,000 | – | – | 200,000 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Award | +200,000 | – | – | 294,467 |
| James Nathaniel Powell Chief Executive Officer | Jan 2, 2026 | Tax withholding | −2,464 | $0.59 | $1.45K | 125,593 |
| Paul T. Lehr General Counsel, Secretary | Jan 2, 2026 | Tax withholding | −6,952 | $0.59 | $4.10K | 344,177 |
| Lisa Locklear Chief Financial Officer | Jan 2, 2026 | Tax withholding | −10,250 | $0.59 | $6.05K | 228,831 |
| Devin Blass CTO & SVP of CMC | Jan 2, 2026 | Tax withholding | −10,700 | $0.59 | $6.31K | 200,176 |
| Nataliya Agafonova Chief Medical Officer | Jan 2, 2026 | Tax withholding | −10,250 | $0.59 | $6.05K | 216,564 |
| George A. Paletta Jr. Director | Oct 1, 2025 | Award | +34,000 | – | – | 34,000 |
| James Nathaniel Powell Chief Executive Officer | Oct 1, 2025 | Tax withholding | −2,389 | $0.74 | $1.77K | 128,057 |
| Devin Blass CTO & SVP of CMC | Oct 1, 2025 | Tax withholding | −7,609 | $0.74 | $5.63K | 210,876 |
| Nataliya Agafonova Chief Medical Officer | Oct 1, 2025 | Tax withholding | −11,883 | $0.74 | $8.79K | 226,814 |
| Lisa Locklear Chief Financial Officer | Oct 1, 2025 | Tax withholding | −11,883 | $0.74 | $8.79K | 239,081 |
| Paul T. Lehr General Counsel, Secretary | Oct 1, 2025 | Tax withholding | −4,944 | $0.74 | $3.66K | 351,129 |
| James Nathaniel Powell Chief Executive Officer | Sep 4, 2025 | Award | +50,000 | – | – | 130,446 |
| Khoso Baluch Director | Aug 11, 2025 | Buy | +11,766 | – | – | 52,516 |
| Lisa Locklear Chief Financial Officer | Aug 11, 2025 | Buy | +11,766 | – | – | 250,964 |
| Rock Soffer Director | Jul 15, 2025 | Award | +17,000 | – | – | 226,034 |
| Lisa Locklear Chief Financial Officer | Jul 15, 2025 | Award | +102,000 | – | – | 239,198 |
| Roger Joseph Hajjar Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Richard N. Kender Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Neha J. Motwani Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Paul T. Lehr General Counsel, Secretary | Jul 15, 2025 | Award | +102,000 | – | – | 356,073 |
| Nataliya Agafonova Chief Medical Officer | Jul 15, 2025 | Award | +102,000 | – | – | 238,697 |
| Ursula Ungaro Director | Jul 15, 2025 | Award | +17,000 | – | – | 41,000 |
| Khoso Baluch Director | Jul 15, 2025 | Award | +17,000 | – | – | 40,750 |
| Mohamed Wa'el Ahmed Hashad Chief Executive Officer | Jul 15, 2025 | Award | +180,000 | – | – | 420,904 |
| Devin Blass CTO & SVP of CMC | Jul 15, 2025 | Award | +102,000 | – | – | 218,485 |
| Mohamed Wa'el Ahmed Hashad Chief Executive Officer | Jul 1, 2025 | Tax withholding | −13,146 | $1.28 | $16.83K | 240,904 |
| Paul T. Lehr General Counsel, Secretary | Jul 1, 2025 | Tax withholding | −1,562 | $1.28 | $2.00K | 254,073 |
| Devin Blass CTO & SVP of CMC | Jul 1, 2025 | Tax withholding | −4,599 | $1.28 | $5.89K | 116,485 |
| Lisa Locklear Chief Financial Officer | Jul 1, 2025 | Tax withholding | −7,431 | $1.28 | $9.51K | 137,198 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Soffer Rock Director | May 29, 2025 | 21,000 | $26.78K | May 29, 2025 | Purchase - Pre-IPO |
| Joshua Hare Officer, Director | May 15, 2025 | 5,250 | $7.22K | May 15, 2025 | Founder's Equity |
| Khoso Baluch Director | Nov 27, 2024 | 1,250 | $2.58K | Nov 27, 2024 | Open Market Purchase |